HU201353B - Process for microbiological redcingt prostacyclin intermediates containing 15-keto-group - Google Patents
Process for microbiological redcingt prostacyclin intermediates containing 15-keto-group Download PDFInfo
- Publication number
- HU201353B HU201353B HU863159A HU315986A HU201353B HU 201353 B HU201353 B HU 201353B HU 863159 A HU863159 A HU 863159A HU 315986 A HU315986 A HU 315986A HU 201353 B HU201353 B HU 201353B
- Authority
- HU
- Hungary
- Prior art keywords
- group
- keto
- hydroxy
- microbiological
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000000543 intermediate Substances 0.000 title claims description 12
- 230000002906 microbiologic effect Effects 0.000 title description 6
- 229960001123 epoprostenol Drugs 0.000 title description 4
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 title description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000001301 oxygen Substances 0.000 claims abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 3
- 150000002576 ketones Chemical class 0.000 claims abstract description 3
- 241000512906 Candida solani Species 0.000 claims description 9
- 241000235042 Millerozyma farinosa Species 0.000 claims description 9
- 230000009467 reduction Effects 0.000 abstract description 10
- -1 bicyclic prostaglandin Chemical class 0.000 abstract description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 abstract 1
- 101150065749 Churc1 gene Proteins 0.000 abstract 1
- 102100038239 Protein Churchill Human genes 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
- 238000006722 reduction reaction Methods 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 150000003180 prostaglandins Chemical class 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AEBWATHAIVJLTA-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene Chemical compound C1CCC2CCCC21 AEBWATHAIVJLTA-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- CZLVPINBLDRZCJ-UHFFFAOYSA-N 2,3,4,4,5,5,6,6-octachlorocyclohex-2-en-1-one Chemical compound ClC1=C(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C1=O CZLVPINBLDRZCJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241001149669 Hanseniaspora Species 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241001397466 Millerozyma farinosa CBS 185 Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002240 iloprost Drugs 0.000 description 1
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853519548 DE3519548A1 (de) | 1985-05-29 | 1985-05-29 | Mikrobiologische reduktion von prostacyclin-zwischenprodukten mit einer 15-ketogruppe |
| PCT/DE1986/000213 WO1986007092A1 (en) | 1985-05-29 | 1986-05-16 | Microbiological reduction of intermediary products of prostacyclin with a 15-ketonic group |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT45561A HUT45561A (en) | 1988-07-28 |
| HU201353B true HU201353B (en) | 1990-10-28 |
Family
ID=6272112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU863159A HU201353B (en) | 1985-05-29 | 1986-05-16 | Process for microbiological redcingt prostacyclin intermediates containing 15-keto-group |
Country Status (4)
| Country | Link |
|---|---|
| CS (1) | CS258141B2 (cs) |
| DD (1) | DD247465A5 (cs) |
| DE (1) | DE3680110D1 (cs) |
| HU (1) | HU201353B (cs) |
-
1986
- 1986-05-16 DE DE8686903219T patent/DE3680110D1/de not_active Expired - Lifetime
- 1986-05-16 HU HU863159A patent/HU201353B/hu not_active IP Right Cessation
- 1986-05-20 CS CS863658A patent/CS258141B2/cs unknown
- 1986-05-27 DD DD86290625A patent/DD247465A5/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DD247465A5 (de) | 1987-07-08 |
| CS258141B2 (en) | 1988-07-15 |
| HUT45561A (en) | 1988-07-28 |
| DE3680110D1 (de) | 1991-08-08 |
| CS365886A2 (en) | 1987-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU182069B (en) | Process for preparing monacoline k, a compound with antihypercholesteremic activity | |
| EP0599967B1 (en) | Arylalkanoic acid resolution | |
| HU201353B (en) | Process for microbiological redcingt prostacyclin intermediates containing 15-keto-group | |
| EP0272201B1 (de) | Stereospezifische Ketoreduktion von Bicyclooctandion-carbonsäureestern durch Mikroorganismen | |
| EP0012710B1 (de) | Mikrobiologische Reduktion von 15-Keto-prostaglandin-Zwischenprodukten | |
| EP0262126B1 (de) | Mikrobiologische reduktion von prostacyclin-zwischenprodukten mit einer 15-ketogruppe | |
| DE2445581A1 (de) | Verfahren zur herstellung von d-gluconsaeure-delta-lactam | |
| EP0271432B1 (de) | Racematspaltung von 3-Acyloxy-Bicyclo[3.3.0]octan-7-on-2-carbonsäureestern durch stereospezifische enzymatische oder mikrobiologische Acylat-Hydrolyse | |
| US7294492B2 (en) | Process for the manufacture of spiroketals | |
| EP0570593B1 (en) | Process for producing optically active norborneol | |
| US4036876A (en) | 18- AND 19-Hydroxylated prostaglandins | |
| EP0281143B1 (en) | Process for producing mevalonic acid | |
| EP0272605A2 (de) | Verfahren zur Herstellung von optisch aktiven 2-Hydroxybuttersäurederivaten | |
| EP0208662A1 (en) | Process for manufacturing r(-)-norcarnitine tert-butyl ester | |
| DE60116787T2 (de) | Verfahren zur herstellung von pravastatin-natriumsalz mittels streptomyces flavidovirens dsm 14455 | |
| US3835170A (en) | Hypotensive agent, oudenone, its salts and processes for production and preparation thereof | |
| HU204575B (en) | Process for producing 1-methyl-1,4-androstadiene-3,17-dion | |
| US5429934A (en) | Process for the production of 20-methyl-5,7-pregnadiene-3β,21-diol derivatives using mycobacterium | |
| DE68914469T2 (de) | Verfahren zur Herstellung von Optisch aktives Bicyclo[3.3.0]octan. | |
| WO1988003569A1 (en) | Process for producing optically active bicyclo[3.3.0]octandione carboxylic acid esters | |
| DE3527335A1 (de) | Verfahren zur mikrobiellen hydroxylierung von forskolin und seinen derivaten durch mortierella-staemme | |
| FR2723748A1 (fr) | Substances physiologiquement actives de type caledothricine, procede pour leur production, compositions pharmaceutiques les contenant et leur utilisation | |
| JPH10127299A (ja) | 光学活性グリシド酸エステル及び光学活性グリセリン酸エステルの製造方法 | |
| BE549568A (cs) | ||
| JP2004531246A (ja) | ヒト血小板凝集および大豆リポキシゲナーゼの阻害剤の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |